Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY V BURTON

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1316968761
CMS profile
486527
Location
SHREVEPORT, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,938.98

97 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,938.98 97

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 97 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY V BURTON

NPI 1316968761 · CMS profile ID 486527

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SHREVEPORT, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 97 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY V BURTON, NPI 1316968761, CMS profile ID 486527. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 97 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). GARY V BURTON, NPI 1316968761, CMS profile ID 486527. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 97 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
GARY V BURTON, NPI 1316968761, CMS profile ID 486527, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 97 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1316968761?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

97 matching records · $1,938.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 97 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 97.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $21.8012/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044398219 CMS
Janssen Biotech, Inc. $18.7612/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181447 CMS
Seagen Inc. $16.2612/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696335 CMS
Merck Sharp & Dohme LLC $22.6512/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048262509 CMS
Neurocrine Biosciences, Inc. $22.0012/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052339911 CMS
Seagen Inc. $13.3512/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696321 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.7811/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000509481 CMS
Janssen Biotech, Inc. $12.0511/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181425 CMS
Novartis Pharmaceuticals Corporation $28.4411/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805389 CMS
AVEO Pharmaceuticals, Inc. $18.0011/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049059031 CMS
Puma Biotechnology, Inc. $17.2410/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059052885 CMS
Seagen Inc. $14.5410/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696307 CMS
Daiichi Sankyo Inc. $29.5310/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006510361 CMS
PFIZER INC. $20.3810/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049129817 CMS
GlaxoSmithKline, LLC. $17.7210/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001356139 CMS
Genentech USA, Inc. $17.1610/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040367197 CMS
Janssen Biotech, Inc. $18.2010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181435 CMS
Pharmacyclics LLC, An AbbVie Company $18.6210/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998282795 CMS
Stemline Therapeutics Inc. $21.7310/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040026337 CMS
Celgene Corporation $15.8210/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774327 CMS
Mirati Therapeutics, Inc. $12.7310/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057987405 CMS
Eisai Inc. $16.5809/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023310967 CMS
Seagen Inc. $13.8309/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696201 CMS
Genmab U.S., Inc. $21.2909/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051344533 CMS
E.R. Squibb & Sons, L.L.C. $13.1309/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774319 CMS
Daiichi Sankyo Inc. $25.4809/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006494799 CMS
Amgen Inc. $19.8009/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019913857 CMS
Gilead Sciences, Inc. $13.4109/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026037059 CMS
Lilly USA, LLC $95.4709/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031383567 CMS
Genentech USA, Inc. $13.8709/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040367191 CMS
Daiichi Sankyo Inc. $29.6109/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006491689 CMS
Gilead Sciences, Inc. $17.9809/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025894121 CMS
Daiichi Sankyo Inc. $12.5008/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006491187 CMS
Janssen Biotech, Inc. $17.8908/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181407 CMS
Janssen Biotech, Inc. $1.7308/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988181417 CMS
GENZYME CORPORATION $14.2608/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050069695 CMS
Gilead Sciences, Inc. $14.3008/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026015253 CMS
Puma Biotechnology, Inc. $13.9908/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059050083 CMS
Astellas Pharma US Inc $17.7108/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034415751 CMS
Daiichi Sankyo Inc. $23.5508/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006459728 CMS
Novartis Pharmaceuticals Corporation $17.7808/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805369 CMS
Novartis Pharmaceuticals Corporation $20.0108/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805365 CMS
Merck Sharp & Dohme LLC $21.2808/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048851725 CMS
Novartis Pharmaceuticals Corporation $26.1708/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991805385 CMS
Genmab U.S., Inc. $17.5308/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051344535 CMS
Karyopharm Therapeutics Inc. $20.3408/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056900439 CMS
MENARINI SILICON BIOSYSTEMS, INC. $19.3708/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034674289 CMS
E.R. Squibb & Sons, L.L.C. $24.6108/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015774307 CMS
Pharmacyclics LLC, An AbbVie Company $16.8808/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998282793 CMS
Seagen Inc. $14.5707/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995696105 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $309.04 18
PY2020 $162.87 10
PY2021 $114.40 7
PY2022 $794.52 48
PY2023 $1,938.98 97
PY2024 $3,064.02 111
PY2025 $3,313.07 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $235,114.26 4
PY2024 Principal investigator $103,440.40 8
PY2023 Principal investigator $91,467.77 8
PY2022 Principal investigator $12,951.85 6
PY2021 Principal investigator $4,321.37 3
PY2020 Principal investigator $960.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $435.09 12/31/2023 Non-covered Recipient Entity
Louisiana State University Health Sciences Center
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 1042497773
Principal investigator 1 Merck Sharp & Dohme LLC $11,613.37 12/31/2023 Non-covered Recipient Entity
Louisiana State University Health Sciences Shreveport
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative HR,HER2- in locally recurrent inoperable or Metastatic Breast Cancer KEYNOTE-B49 No dispute reported 06/30/2026 1042520011
Principal investigator 1 Merck Sharp & Dohme LLC $30,039.26 12/31/2023 Non-covered Recipient Entity
Louisiana State University Health Sciences Shreveport
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative HR,HER2- in locally recurrent inoperable or Metastatic Breast Cancer KEYNOTE-B49 No dispute reported 06/30/2026 1042520021
Principal investigator 1 Merck Sharp & Dohme LLC $25,550.00 12/11/2023 Non-covered Recipient Entity
LSU-HSC-SHREVEPORT
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative HR,HER2- in locally recurrent inoperable or Metastatic Breast Cancer KEYNOTE-B49 No dispute reported 06/30/2026 1042519849
Principal investigator 1 Veru Inc. $2,250.00 09/14/2023 Non-covered Recipient Entity
LSU HEALTH SCIENCES CENTER SHREVEPORT
VERU_V3002401_4063_01 No dispute reported 06/30/2026 1058357849
Principal investigator 1 PFIZER INC. $17,687.00 06/30/2023 Non-covered Recipient Entity
LSU Health Sciences Center Shreveport General Fund
A PHASE 3 RANDOMIZED OPENLABEL MULTICENTER TRIAL OF ARV471 PF07850327 VS FULVESTRANT IN PARTICIPANTS WITH ESTROGEN RECEPTORPOSITIVE HER2NEGATIVE ADVANCED BREAST CANCER WHOSE DISEASE PROGRESSED AFTER PRIOR ENDOCRINE BASED TREATMENT FOR ADVANCED DISEASE VERITAC2 No dispute reported 06/30/2026 1046324669
Principal investigator 1 Veru Inc. $1,000.00 04/20/2023 Non-covered Recipient Entity
LSU HEALTH SCIENCES CENTER SHREVEPORT
VERU_V3002401_4063_01 No dispute reported 06/30/2026 1058356259
Principal investigator 1 Veru Inc. $2,893.05 01/06/2023 Non-covered Recipient Entity
LSU HEALTH SCIENCES CENTER SHREVEPORT
VERU_V3002401_4063_01 No dispute reported 06/30/2026 1058355197